Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Steinbach

Showing results (201-210 of 369) with videos related to

Pageof 37
Sort By:
Cell Death Discovery|January 5, 2024
Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell deathBenedikt Sauer, Nadja I Lorenz, Iris Divé, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2019
<sup>18</sup>F-FET PET Imaging in Differentiating Glioma Progression from Treatment-Related Changes: A Single-Center ExperienceGabriele D Maurer, Daniel P Brucker, Gabriele Stoffels, et al.
Brain : a Journal of Neurology|September 6, 2007
Long-term survival with glioblastoma multiformeDietmar Krex, Barbara Klink, Christian Hartmann, et al.
Cell Death Discovery|August 26, 2024
Superoxide dismutase 1 mediates adaptation to the tumor microenvironment of glioma cells via mammalian target of rapamycin complex 1Sven König, Florian Strassheimer, Nadja I Brandner, et al.
Clinical Epigenetics|December 11, 2024
DNA methylation-based analysis reveals accelerated epigenetic aging in giant cell-enriched adult-type glioblastomaPinar Cakmak, Philipp Jurmeister, Iris Divé, et al.
American Journal of Human Genetics|June 1, 1997
Characterization of FMR1 promoter elements by in vivo-footprinting analysisS Schwemmle, E de Graaff, H Deissler, et al.
The Journal of Biological Chemistry|December 23, 2018
Disruption of peroxisome proliferator-activated receptor γ coactivator (PGC)-1α reverts key features of the neoplastic phenotype of glioma cellsInes Bruns, Benedikt Sauer, Michael C Burger, et al.
Oncology|July 28, 2011
Ifosfamide, carboplatin and etoposide in recurrent malignant gliomaN Schäfer, J Tichy, S Thanendrarajan, et al.
Cancer Research|May 1, 2002
Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastomaJörg Wischhusen, Gundram Jung, Ivan Radovanovic, et al.
Journal of Cancer Research and Clinical Oncology|February 4, 2021
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapyEike Steidl, Katharina Filipski, Pia S Zeiner, et al.
Pageof 37

Showing results (201-210 of 369) with videos related to

Sort By:
Pageof 37
Cell Death Discovery|January 5, 2024
Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell deathBenedikt Sauer, Nadja I Lorenz, Iris Divé, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2019
<sup>18</sup>F-FET PET Imaging in Differentiating Glioma Progression from Treatment-Related Changes: A Single-Center ExperienceGabriele D Maurer, Daniel P Brucker, Gabriele Stoffels, et al.
Brain : a Journal of Neurology|September 6, 2007
Long-term survival with glioblastoma multiformeDietmar Krex, Barbara Klink, Christian Hartmann, et al.
Cell Death Discovery|August 26, 2024
Superoxide dismutase 1 mediates adaptation to the tumor microenvironment of glioma cells via mammalian target of rapamycin complex 1Sven König, Florian Strassheimer, Nadja I Brandner, et al.
Clinical Epigenetics|December 11, 2024
DNA methylation-based analysis reveals accelerated epigenetic aging in giant cell-enriched adult-type glioblastomaPinar Cakmak, Philipp Jurmeister, Iris Divé, et al.
American Journal of Human Genetics|June 1, 1997
Characterization of FMR1 promoter elements by in vivo-footprinting analysisS Schwemmle, E de Graaff, H Deissler, et al.
The Journal of Biological Chemistry|December 23, 2018
Disruption of peroxisome proliferator-activated receptor γ coactivator (PGC)-1α reverts key features of the neoplastic phenotype of glioma cellsInes Bruns, Benedikt Sauer, Michael C Burger, et al.
Oncology|July 28, 2011
Ifosfamide, carboplatin and etoposide in recurrent malignant gliomaN Schäfer, J Tichy, S Thanendrarajan, et al.
Cancer Research|May 1, 2002
Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastomaJörg Wischhusen, Gundram Jung, Ivan Radovanovic, et al.
Journal of Cancer Research and Clinical Oncology|February 4, 2021
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapyEike Steidl, Katharina Filipski, Pia S Zeiner, et al.
Pageof 37